AbbVie Asks High Court To Review Sham Litigation Exception
AbbVie Inc. asked the U.S. Supreme Court on Thursday to review the Third Circuit's ruling that determined the biopharmaceutical company's patent-infringement suit was a sham after it was accused of delaying...To view the full article, register now.
Already a subscriber? Click here to view full article